Publications: Our research

Filter
Research Area
Technology
Resource type
Category
146 results found
Oct 16, 2024
Publication
Novavax led
JMIR public health and surveillance
COVID-19 Vaccine Preferences in General Populations in Canada, Germany, the United Kingdom, and the United States: Discrete Choice Experiment
David Salisbury, Jeffrey V Lazarus, Nancy Waite, et al.
Oct 11, 2024
Preprint
Novavax led
Seasonal influenza, Matrix-M™ adjuvant
A Modified Novel Validated High-Throughput Hemagglutinin Inhibition Assay Using Recombinant Virus-Like Particles and Human Red Blood Cells for the Objective Evaluation of Recombinant Hemagglutinin Nanoparticle Seasonal Influenza Vaccine
Timothy S. Vincent, Mingzhu Zhu, Anand Parekh, et al.
Sep 27, 2024
Publication
Novavax led
Journal of Infection
COVID-19, Matrix-M™ adjuvant
Immunogenicity and Safety of SARS-CoV-2 Recombinant Spike Protein Vaccine in South African People Living With and Without HIV-1 Infection: A Phase 2 Randomised Trial
Chijioke Bennett, Zaheer Hoosain, Anthonet Koen, et al.
Jul 19, 2024
Publication
Novavax led
Vaccines
COVID-19, Matrix-M™ adjuvant
Reactogenicity Differences between Adjuvanted, Protein-Based and Messenger Ribonucleic Acid (mRNA)-Based COVID-19 Vaccines
Matthew D. Rousculp, Kelly Hollis, Ryan Ziemiecki, et al.
Jul 14, 2024
Publication
Novavax led
microorganisms
COVID-19, Matrix-M™ adjuvant
Validation of a Pseudovirus Neutralization Assay for Severe Acute Respiratory Syndrome Coronavirus 2: A High-Throughput Method for the Evaluation of Vaccine Immunogenicity
Raj Kalkeri, Ph.D., Mingzhu Zhu, Ph.D., Shane Cloney-Clark B.Sc, et al.
Jul 5, 2024
Preprint
Novavax led
medRxiv
COVID-19, Matrix-M™ adjuvant
Short-Term Relative Effectiveness of Homologous NVX-CoV2373 and BNT162b2 COVID-19 Vaccinations in South Korea
Eunseon Gwak, Seung-Ah Choe, Erdenetuya Bolormaa, et al.
Jun 25, 2024
Preprint
Novavax led
medRxiv
COVID-19, Matrix-M™ adjuvant
Reactogenicity Differences between COVID-19 Vaccines: A Prospective Observational Study in the United States and Canada
Matthew D. Rousculp, Kelly Hollis, Ryan Ziemiecki, et al.
Apr 23, 2024
Publication
Collaborative
BMC Medicine
Malaria, Matrix-M™ adjuvant
A Pfs48/45‑based vaccine to block Plasmodium falciparum transmission: phase 1, open‑label, clinical trial
M. Alkema, M. J. Smit, C. Marin‑Mogollon, et al.
Apr 20, 2024
Publication
Novavax led
Journal of Virological Methods
COVID-19, Matrix-M™ adjuvant
Validation of a severe acute respiratory syndrome coronavirus 2 microneutralization assay for evaluation of vaccine immunogenicity
Stephanie Hamilton, Mingzhu Zhu, Shane Cloney Clark, et al.
Apr 6, 2024
Publication
Novavax led
Vaccines
COVID-19, Matrix-M™ adjuvant
Characteristics and Outcomes for Recipients of NVX-CoV2373: A Real-World Retrospective Study in Germany
Lucie Kutikova, James T. Brash, Kawitha Helme, et al.